The downgrade is a result of several factors, including ProMedica’s high leverage, weaker operating performance and reduced liquidity metrics. S&P favorably viewed ProMedica’s strong market position, solid unrestricted reserves and manageable debt burden.
The outlook is stable, reflecting ProMedica’s strong business position and ongoing strategic investments.
More articles on healthcare finance:
UCLA Health to establish health sciences learning center with $20M gift
7 latest hospital credit downgrades
10 hospitals seeking RCM talent
